1379322-06-1

Basic information

• Product Name: tert-Butyl ((3-aMinooxetan-3-yl)Methyl)carbaMate
• Synonyms: tert-Butyl ((3-aMinooxetan-3-yl)Methyl)carbaMate;tert-Butyl N-[(3-aminooxetan-3-yl)methyl]carbamate;(3-Amino-oxetan-3-ylmethyl)-carbamic acid tert-butyl ester
• CAS NO: 1379322-06-1
• Molecular Formula: C₉H₁₈N₂O₃
• Molecular Weight: 202.25082
• Mol File: 1379322-06-1.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: tert-Butyl ((3-aMinooxetan-3-yl)Methyl)carbaMate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-Butyl ((3-aMinooxetan-3-yl)Methyl)carbaMate(1379322-06-1)
• EPA Substance Registry System: tert-Butyl ((3-aMinooxetan-3-yl)Methyl)carbaMate(1379322-06-1)

Safety Data

• Hazardous Substances Data: 1379322-06-1(Hazardous Substances Data)

Usage

General Description

Tert-butyl ((3-aminooxetan-3-yl)methyl)carbamate is a chemical compound with a molecular formula C10H20N2O3. It is a tert-butyl carbanate derivative with a substituted oxetane ring and an amino group. tert-Butyl ((3-aMinooxetan-3-yl)Methyl)carbaMate is commonly used in organic synthesis as a reagent for the preparation of various pharmaceuticals and agrochemicals. It has also been studied for its potential as an antiparasitic and antifungal agent. Its unique structural properties make it a versatile building block for the synthesis of diverse organic compounds, and it is important for the development of new drugs and functional materials.

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 1422496-53-4 (3-dibenzylamino-oxetan-3-ylmethyl)carbamic acid tert-butyl ester 

Relevant articles and documents

Oxetanyl Amino Acids for Peptidomimetics

Peptides are important in the drug discovery process. In analogy to nonpeptidic small-molecule counterparts, they can sometimes suffer from disadvantages such as their low bioavailability and poor metabolic stability. Herein, we report the synthesis of new oxetanyl dipeptides and their incorporation into Leu-enkephalin analogues as proof-of-principle studies. The modular approach that is described enables the incorporation of a variety of oxetanyl amino acids into potential peptide therapeutics.

SPIROCYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS

The present invention relates to Spirocyclic Heterocycle Compounds of Formula (I): (I) and pharmaceutically acceptable salts thereof, wherein A, B, X, R1, R2, R3 and R4 are as defined herein. The present invention also relates to compositions comprising at least one Spirocyclic Heterocycle Compound, and methods of using the Spirocyclic Heterocycle Compounds for treating or preventing HIV infection in a subject.

COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS DISEASE

A compound of formula (I) as well as pharmaceutically acceptable salt thereof, wherein R1, R2 and X are as defined in description and in claims, can be used as a medicament.